LATS1 and Alzheimer disease: After confirming the efficacy of ablation of Lats1 and Lats2 to inhibit downstream Hippo signaling activity, we set out to determine how inhibition of Hippo signaling activity might affect cognition and AD‐related pathology in 5xFAD mice.